Results 11 to 20 of about 22,234 (251)

Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. [PDF]

PLoS Neglected Tropical Diseases, 2014
BackgroundStudies of the immunogenicity of the killed bivalent whole cell oral cholera vaccine, Shanchol, have been performed in historically cholera-endemic areas of Asia.
Richelle C Charles, Isabelle J Hilaire, Leslie M Mayo-Smith, Jessica E Teng, J Gregory Jerome, Molly F Franke, Amit Saha, Yanan Yu, Paul Kováč, Stephen B Calderwood, Edward T Ryan, Regina C LaRocque, Charles P Almazor, Firdausi Qadri, Louise C Ivers, Jason B Harris   +15 more
doaj   +5 more sources

An Estimation of Private Household Costs to Receive Free Oral Cholera Vaccine in Odisha, India. [PDF]

PLoS Neglected Tropical Diseases, 2015
BACKGROUND:Service provider costs for vaccine delivery have been well documented; however, vaccine recipients' costs have drawn less attention. This research explores the private household out-of-pocket and opportunity costs incurred to receive free oral
Vittal Mogasale, Shantanu K Kar, Jong-Hoon Kim, Vijayalaxmi V Mogasale, Anna S Kerketta, Bikash Patnaik, Shyam Bandhu Rath, Mahesh K Puri, Young Ae You, Hemant K Khuntia, Brian Maskery, Thomas F Wierzba, Binod Sah   +12 more
doaj   +3 more sources

Oral vaccines for preventing cholera [PDF]

Cochrane Database of Systematic Reviews, 2010
This review is superseded by the published Cochrane Review, Saif‐Ur‐Rahman 2024 [https://doi.org/10.1002/14651858.CD014573], which considers only the oral killed vaccines because the live oral vaccines do not have World Health Organization (WHO) prequalification. Saif‐Ur‐Rahman 2024 also considered only currently available WHO pre‐qualified oral killed
Sinclair, David, Abba, Katharine, Zaman, K., Qadri, Firdausi, Graves, Patricia M.   +4 more
openaire   +5 more sources

Controlling cholera in the Ouest Department of Haiti using oral vaccines. [PDF]

PLoS Neglected Tropical Diseases, 2017
Following the 2010 cholera outbreak in Haiti, a plan was initiated to provide massive improvements to the sanitation and drinking water infrastructure in order to eliminate cholera from the island of Hispaniola by 2023.
Alexander Kirpich, Thomas A Weppelmann, Yang Yang, John Glenn Morris, Ira M Longini   +4 more
doaj   +3 more sources

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance [PDF]

BMC Public Health, 2009
Background Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Chaignat Claire-Lise, Weiss Mitchell G, Pach Al, Ali Said M, Hutubessy Raymond, Schaetti Christian, Khatib Ahmed M   +6 more
doaj   +2 more sources

Global oral cholera vaccine use, 2013–2018

Vaccine, 2020
Vaccination is a key intervention to prevent and control cholera in conjunction with water, sanitation and hygiene activities. An oral cholera vaccine (OCV) stockpile was established by the World Health Organization (WHO) in 2013. We reviewed its use from July 2013 to all of 2018 in order to assess its role in cholera control.
Pezzoli, L., Oral Cholera Vaccine Working Group of the Global Task Force on C   +1 more
openaire   +5 more sources

Cost of oral cholera vaccine delivery in a mass immunization program for children in urban Bangladesh. [PDF]

Vaccine X, 2022
Sarker AR, Khan AI, Islam MT, Chowdhury F, Khanam F, Kang S, Ahmmed F, Im J, Kim DR, Tadesse BT, Ahmed T, Aziz AB, Hoque M, Park J, Liu X, Pak G, Zaman K, Marks F, Kim JH, Clemens JD, Qadri F.   +20 more
europepmc   +2 more sources

Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12-17 Years in the United States. [PDF]

Am J Trop Med Hyg, 2021
McCarty JM, Cassie D, Bedell L, Lock MD, Bennett S.   +4 more
europepmc   +3 more sources

Comprehensive Review on the Use of Oral Cholera Vaccine (OCV) in Ethiopia: 2019 to 2023. [PDF]

Clin Infect Dis
Edosa M, Jeon Y, Gedefaw A, Hailu D, Mesfin Getachew E, Mogeni OD, Jang GH, Mukasa D, Yeshitela B, Getahun T, Lynch J, Bouhenia M, Worku Demlie Y, Hussen M, Wossen M, Teferi M, Park SE.   +16 more
europepmc   +3 more sources

Assessment of the influence of ABO blood groups on oral cholera vaccine immunogenicity in a cholera endemic area in Zambia. [PDF]

BMC Public Health, 2023
Chisenga CC, Bosomprah S, Chilyabanyama ON, Alabi P, Simuyandi M, Mwaba J, Ng'ombe H, Laban NM, Luchen CC, Chilengi R.   +9 more
europepmc   +3 more sources